Charles River Laboratories International (NYSE:CRL – Get Free Report) and Bio-Rad Laboratories (NYSE:BIO.B – Get Free Report) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, valuation, profitability and risk. Earnings & Valuation This table compares […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) CAO Michael Gunnar Knell sold 6,645 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $260.38, for a total value of $1,730,225.10. Following the completion of the sale, the chief accounting […]

Charles River Laboratories International (NYSE:CRL) reported second-quarter results that exceeded its prior outlook, citing improved demand in its Discovery and Safety Assessment, or DSA, business and stronger-than-expected manufacturing performance. The company raised its full-year revenue, earnings and free-cash-flow guidance while maintaining a cautious view that the recovery in biopharmaceutical demand will progress gradually. Chief Executive […]

Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) EVP Shannon Parisotto sold 5,046 shares of the firm’s stock in a transaction dated Wednesday, August 5th. The stock was sold at an average price of $263.00, for a total transaction of $1,327,098.00. Following the transaction, the executive vice president owned 4,807 shares of the […]